This spectrum consists of isolated hepatic macrovesicular steatosis at one end and nonalcoholic steatohepatitis (NASH) at the other. Hepatic steatosis is present in ~50% of the subjects with HCV.

There were no differences in these variables related to gender. Steatosis was detected in 50 children (34.7%; 95% CI 26.0–42.0%). The values differed related to the gender (40.5% in males and 26 ...